People · Operator

John Warner

Named in public records as an officer, director or promoter · active 2011–2019 · Other, Medical Devices, Pharmaceuticals

3
Companies
4
Filings
$6.0M
Combined raised · real
Serial
Operator type
Companies
CompanyRoleSectorStageRaised · realValue · estTied
InnoVenture 2012 Investors LPOtherSeries A$5.0M$12.5M
Accessible Diagnostics LLCMedical DevicesPre-Seed$719K$8.1M2017
Occam Sciences, Inc.PharmaceuticalsPre-Seed$300K$14.2M2011
Operator network

John Warner at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.

Brian McSharry · 5 companies · 1 sharedBrian McSharryBenjamin Walvoord · 1 companies · 1 sharedBenjamin WalvoordDavid Dawkins · 1 companies · 1 sharedDavid DawkinsDelphine Dean · 1 companies · 1 sharedDelphine DeanNigel Clarke · 1 companies · 1 sharedNigel ClarkeRebecca Silveston-Keith · 1 companies · 1 sharedRebecca Silveston…Brian Dixon · 3 companies · 1 sharedBrian DixonRobert Bettigole · 2 companies · 1 sharedRobert BettigoleDavid Whittaker · 1 companies · 1 sharedDavid WhittakerJoseph Pont · 1 companies · 1 sharedJoseph PontMerton G. Gollaher · 1 companies · 1 sharedMerton G. GollaherInnoVenture 2012 Investors LP · $5.0M raisedInnoVenture 2012 Inve…Accessible Diagnostics LLC · $0.7M raisedAccessible Diagnostic…Occam Sciences, Inc. · $0.3M raisedOccam Sciences, Inc.John WarnerJW
John Warner Company Co-operator (ring = serial)Hover to isolate ties · click to open
Co-operators (shared boards)

People named alongside John Warner on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.

OperatorSharedTheir companies
Brian McSharry15
Brian Dixon13
Robert Bettigole12
Benjamin Walvoord11
David Dawkins11
Nigel Clarke11
Merton G. Gollaher11
Joseph Pont11
David Whittaker11
Delphine Dean11
Rebecca Silveston-Keith11

People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.